Basiliximab in a triple-drug regimen with tacrolimus and steroids in liver transplantation

Transplantation Proceedings

Volumn 37, Issue 6, 2005, Pages 2611-2613

  Gruttadauria, S ^a   Vasta, F ^a   Mandala L ^a   Cintorino, D ^a   Piazza, T ^a   Spada, M ^a   Verzaro, R ^a   Gridelli, B ^a  

^a MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; METHYLPREDNISOLONE; PREDNISONE; STEROID; TACROLIMUS;

ADOLESCENT; ADULT; AGED; BIOPSY; CADAVER DONOR; CARCINOID; CHILD; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HUMAN; ILEUM CANCER; IMMUNOSUPPRESSIVE TREATMENT; INJECTION SITE REACTION; LIVER CELL CARCINOMA; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROBABILITY; RECIPIENT; SEPSIS; SURVIVAL RATE;

EID: 25144522350     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.06.063     Document Type: Article

References (8)

1. D.C. Brennan Action, efficacy and toxicities polyclonal antilymphocyte antibodies D.J. Norman L.A. Turka Primer on Transplantation 2nd Ed 2001 American Society of Transplantation Mt. Laurel, NJ 152
2. M.A.J. Moser Options for induction immunosuppression in liver transplant recipients Drugs 62 2003 995
3. D. Adu, P. Cockwell, N.J. Ives Interleukin-2 receptor monoclonal antibodies in renal transplantation meta-analysis of randomised trials BMJ 326 2003 789
4. B. Nashan, R. Moore, P. Amlot Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients Lancet 350 1997 1193
5. B.D. Kahan, P.R. Rajagopalan, M. Hall Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody Transplantation 67 1999 276
6. C. Ponticelli, A. Yussim, V. Cambi A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients Transplantation 72 2001 1261
7. J.G. Lawen, E.A. Davies, G. Mourad Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation Transplantation 75 2003 37
8. N. Singh, D.L. Paterson, T. Gayowski Cytomegalovirus antigenemia directed pre-emptive prophylaxis with oral versus I.V. ganciclovir for the prevention of cytomegalovirus disease in liver transplant recipients a randomized, controlled trial Transplantation 70 2000 717